Skip to content
Screener

Foghorn Therapeutics FHTX Q1 2026 earnings

Reported May 7, 2026 · Before market open

Revenue$3.3MMiss by $4.7M
EPS-$0.29Miss by $0.01
Revenue estimate$7.9M
EPS estimate-$0.28

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$7.1M
EPS estimate-$0.22

FAQ

When did Foghorn Therapeutics report Q1 2026 earnings?
Foghorn Therapeutics (FHTX) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Foghorn Therapeutics's Q1 2026 revenue and EPS?
Foghorn Therapeutics reported revenue of $3.3M and eps of $-0.29 for Q1 2026.
Did Foghorn Therapeutics beat estimates in Q1 2026?
Revenue missed the consensus estimate of $7.9M by $4.7M. EPS missed the consensus estimate of $-0.28 by $0.01.
How did Foghorn Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 45.1% from $6.0M a year earlier and eps grew 3.3% from $-0.30.
Where can I find Foghorn Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031669) and the 10-Q periodic report (0001628280-26-031671) directly on SEC EDGAR. The filing index links above go to sec.gov.